Gabapentin preferred over pregabalin for chronic sciatica painGabapentin is more effective and causes fewer and less severe adverse events Medical cannabis for refractory pain and other conditions Opioid warning sticker–patient handout policy takes effect Oct. 20 Pharmacists must supply warning sticker and patient information sheet when dispensing most prescription opioids Nearly 10% of high-risk older patients are prescribed NSAIDs for musculoskeletal pain But short-term use is not associated with an increased risk of cardiovascular or renal complications Colloquium: The role for medical cannabis in chronic pain management Canadian best practices for treatment of opioid use disorder New report outlines range of services that should be available to individuals with or at risk of harm from opioid use Buprenorphine: the underutilized opioid for chronic pain How to use motivational interviewing to taper opioids Guiding patients to accept the idea that opioid tapering could bring benefits. Gabapentin and pregabalin ineffective for chronic low back pain Systematic review and meta-analysis identifies no benefit and increased risk of harm Health Canada seeking feedback on proposal for stricter control of tramadol Proposing to reclassify tramadol from a prescription drug to a Schedule I narcotic First Previous 16 17 18 19 20 Next Last
